Aptahem AB
556970-5782ActiveBiotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Biotechnology Companyaptahem.com
Översikt
- 1–4
- Anställda
- ≤1t SEK
- Omsättning
- 2014
- Grundat
Nyckelbeslutsfattare
Mikael Lindstam
CEO
Beskrivning
Aptahem is a specialized biotechnology company focused on developing novel RNA-based pharmaceuticals. Their primary mission is to create disruptive treatments for acute, life-threatening inflammatory diseases, such as sepsis. The company's lead drug candidate, Apta-1, is currently progressing throug...
Taggar
B2BPharmaceuticals
Nyckelord
AptamersBiotechnology